Pipelle endometrial sampling in patients with known endometrial carcinoma

Stovall, TG; Photopulos, GJ; Poston, W.; Ling, F W; Sandles, LG

doi:10.1016/0020-7292(92)90064-p

Cited by 70 publications

(99 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…However, during both procedures, none of the patients complained of severe pain and no complications occurred. This suggests that both outpatient sampling procedures were well tolerated, which is a finding consistent with those of previous reports [6,17,20]. Our data indicated a certain diagnostic superiority of outpatient tissue biopsy to cytologic examination.…”

Section: Discussionsupporting

confidence: 92%

“…However, there are several studies on the use of the Pipelle ® device, which is similar to Suresample ™ [4][5][6][7]13,15,16]. A meta-analysis revealed that the Pipelle ® device has a sensitivity of 99.6% and 91% in postmenopausal and premenopausal patients, respectively [5].…”

Section: Discussionmentioning

confidence: 99%

“…The adverse effects of the Pipelle ® device, used without anesthesia, have been evaluated by surveying 40 patients. Although 2 patients (5%) complained of severe pain, none of the biopsy attempts were prematurely terminated as a result of pain and no complications related to endometrial sampling occurred [6]. The incidence and intensity of pain during and after a cytologic procedure using Endocyte ® have also been examined.…”

Section: Discussionmentioning

confidence: 99%

“…This procedure is easy to perform, associated with minimal patient discomfort, and reported to be highly sensitive in detecting endometrial carcinoma [4][5][6][7][8][9][10][11][12][13][14]. The Pipelle de Cornier ® device (Laboratoire CCD, Paris, France) is an endometrial biopsy sampler that is seemingly better tolerated by patients than most other endometrial biopsy devices [15,16].…”

Section: Introductionmentioning

confidence: 99%

See 3 more Smart Citations

Comparison of Two Sampling Procedures for Diagnosing Endometrial Carcinoma and Hyperplasia: Outpatient Tissue Biopsy Versus Cytologic Examination

Motegi¹,

Tanaka²,

Tada³

et al. 2011

J Cytol Histol

View full text Add to dashboard Cite

IntroductionEach year, there are about 142,000 new cases of endometrial carcinoma worldwide, and an estimated 42,000 women die because of this type of cancer [1]. The surgical stage, determined according to the criteria of the International Federation of Gynecology and Obstetrics, reflects the 5-year survival, which is around 85% for stage I, 75% for stage II, 45% for stage III, and 25% for stage IV disease [1]. Endometrial cancer is often preceded by endometrial hyperplasia, which is a spectrum of morphologic and biologic alterations of the endometrial glands and stroma and is often secondary to hyperestrogenism. It has been shown that progression to carcinoma occurs in 1% of patients with simple hyperplasia, 3% of patients with complex hyperplasia, 8% of patients with simple hyperplasia with atypia, and 29% of patients with complex hyperplasia with atypia [2].The Japanese Ministry of Health and Welfare investigated the effectiveness of mass endometrial carcinoma screening. During the 9-year study, 126 cases were detected by mass screening and 1,069 cases were diagnosed in outpatient clinics. Early-stage cases were significantly more frequent in the screening group (p < 0.001): 88.1% of the patients in the screening group had stage I disease, as compared to 65.3% of the patients in the outpatient group. The 5-year survival rate was also significantly higher in the screening group than in the outpatient group (94.7% vs 84.3%; p = 0.041) [3]. These statistics suggest that early detection of endometrial carcinoma and hyperplasia is necessary to improve the prognosis of these diseases. AbstractBackground: We compared the sensitivity of 2 diagnostic procedures-tissue biopsy and cytologic examinationfor detecting endometrial carcinoma and hyperplasia in outpatients. The patients' degree of acceptance of these methods was also evaluated.

show abstract

Section: Discussionsupporting

confidence: 92%

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Comparison of Two Sampling Procedures for Diagnosing Endometrial Carcinoma and Hyperplasia: Outpatient Tissue Biopsy Versus Cytologic Examination

Motegi¹,

Tanaka²,

Tada³

et al. 2011

J Cytol Histol

View full text Add to dashboard Cite

show abstract

“…The popularity of the Pipelle® for office endometrial sampling dates from the early 1990s. Stovall et al [4] reported in 1991 a 97.5 % sensitivity of Pipelle® sampling for endometrial cancer. This study is not very robust since only 40 patients with known endometrial cancer were included.…”

Section: Introductionmentioning

confidence: 99%

Ultrasound examination before, during, and after office endometrial sampling

2013

View full text Add to dashboard Cite

Office endometrial sampling is widely used as the first diagnostic test in women with abnormal uterine bleeding. Because office sampling is a blind procedure, the lesion causing the symptoms may be missed. The use of ultrasound before, during, and after office endometrial sampling improves relevant tissue yield. The measurement of the endometrial thickness informs if sampling is indicated. The evaluation of ultrasound features (without or with fluid instillation) may suggest a focal intracavitary lesion necessitating operative hysteroscopy. The knowledge of the uterine cavity length, shape, and flexion may avoid nonrepresentative sampling. The concordance between the tissue yield and the ultrasound findings reflects the reliability of the sampling. If not concordant, further diagnostic steps such as fluid instillation sonography or hysteroscopy are indicated. We conclude that integrating ultrasound in the diagnostic algorithm for uterine intracavitary pathology optimizes office endometrial sampling.

show abstract